IndiaA Danish study published in The Lancet Regional Health – Europe suggests that starting statins soon after a type 2 diabetes diagnosis may reduce the risk of dementia by 15% over ten years. The research analyzed data from 132,585 Danes diagnosed with type 2 diabetes between 2006 and 2019, tracking their health outcomes until 2021. Participants were divided into three groups based on when they started statins: within the first year, between one and five years, or none. Those who began statins early showed a 15% lower relative risk of dementia compared to non-starters, while late starters saw a 10% reduction. The study notes that while there is an association between statin use and reduced dementia risk, it does not establish causation, as the research was observational rather than experimental.
Bias read (Center): The article presents a scientific study without overt ideological framing. It discusses medical findings and statistical correlations without promoting a specific political agenda. While the topic relates to public health policy, the tone remains neutral, focusing on presenting the study's results,其
